Activated immune cells in Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Activated immune cells in Parkinson's disease.

Activated immune cells in Parkinson's disease.

http://www.wikidata.org/entity/Q37873407

about

Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease Role of microglia in CNS inflammation Inflammatory regulation of ATP binding cassette efflux transporter expression and function in microglia Converging mediators from immune and trophic pathways to identify Parkinson disease dementia.Metformin Prevents Dopaminergic Neuron Death in MPTP/P-Induced Mouse Model of Parkinson's Disease via Autophagy and Mitochondrial ROS Clearance Targeting metabolic inflammation in Parkinson's disease: implications for prospective therapeutic strategies.Toll-like receptor 4 signaling is involved in PACAP-induced neuroprotection in BV2 microglial cells under OGD/reoxygenation.Innate and adaptive immune responses in neurodegeneration and repair.6-Hydroxydopamine as a tool to understand adaptive immune system-induced dopamine neurodegeneration in Parkinson's disease.Peripheral Blood Monocyte Tolerance Alleviates Intraperitoneal Lipopolysaccharides-Induced Neuroinflammation in Rats Via Upregulating the CD200R Expression.Naloxone inhibition of lipopolysaccharide-induced activation of retinal microglia is partly mediated via the p38 mitogen activated protein kinase signalling pathway.

P2860

Q26849232-AF7FCC6D-13FC-4BA8-B527-C7140811FC88 Q27023760-D9C99493-5EB3-4725-ADC5-13F196BAC1E2 Q34401462-B5A2A6E8-917B-4070-ACC4-4F728070169A Q36521242-E9F61A57-D9F6-42C7-A126-360115002A81 Q37299382-4D27C1E6-D6FC-4507-82C8-FC879DEF5647 Q37962621-36B8967A-AD63-4CEE-B5E2-54977E656EE8 Q39340625-54605ABE-717C-4512-889C-113B95E92E71 Q44581205-DE68DBBB-7487-4D36-8E42-35737334D930 Q48077401-C992EA2E-9A92-4BC5-8E85-1A5EECB68331 Q48218418-4928F081-BADB-4DA0-A230-E0E5F7F0139A Q54484453-DDDFAB31-27BA-4254-8881-1DAD43005186

P2860

Activated immune cells in Parkinson's disease.

http://www.wikidata.org/entity/Q37873407

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Activated immune cells in Parkinson's disease.

@en

Activated immune cells in Parkinson's disease.

@nl

type

label

Activated immune cells in Parkinson's disease.

@en

Activated immune cells in Parkinson's disease.

@nl

prefLabel

Activated immune cells in Parkinson's disease.

@en

Activated immune cells in Parkinson's disease.

@nl

P1433

Q37873407-BF469DD3-4538-48FF-A975-94E3353E43B2

P1476

Q37873407-A3D71F04-65A8-4F71-886C-67A22113ADB4

P2093

Q37873407-0FE4499A-5A71-48CC-9371-06057D024918

Q37873407-27168D11-4575-4302-8F49-4274ACD5A228

Q37873407-B89812F6-EE41-49A3-8D73-37F5F8EFE9B9

P2860

Q37873407-03304A2F-B6C8-4721-AD1F-EC9D2D14C0C4

Q37873407-0C250B4E-2648-4F3A-ABE7-04A040790621

Q37873407-12DE3B4F-E359-4DB7-AC75-6F2EF1EA3B85

Q37873407-173514D9-3AE9-41A5-8D81-04AE2A894C27

Q37873407-2464DB2B-93A2-4E37-92DA-9528A87D9849

Q37873407-2DB4FADD-6593-4867-8208-9F7DCC67BC42

Q37873407-2DB8014A-A97E-4847-AE55-BFDD11BC9EE6

Q37873407-2F736B68-4EB7-4013-91CE-026AFB4D9EC7

Q37873407-306B9865-CAD9-402B-B53C-C3A7D06405D4

Q37873407-32F9C9B6-BCBA-4F58-8338-C24B13F98590

P2888

Q37873407-126AB25A-AB08-48E1-B73B-3832BD6890EF

P304

Q37873407-A56F8C29-18BD-449F-9EE1-27A279D07BE9

P31

Q37873407-125053DA-18AD-44B6-8E18-CC3B98311969

P356

Q37873407-75D300C5-1C41-4674-847E-0DAEF8328EC7

P433

Q37873407-F834E805-7E4F-4623-9DFE-73511C74DBD6

P478

Q37873407-54E2FE9D-FA8B-440E-9E75-EBAC7DFF822F

P577

Q37873407-5B62F6C0-3B2E-4B7E-82CC-AE8ED125FDBE

P698

Q37873407-A460F5B8-5487-4C76-8259-7D0B56FD664D

P921

Q37873407-7BD5FFA8-DD80-4F28-ADA4-D2FDDA06B176

P356

S11481-011-9280-9

P1433

Journal of Neuroimmune Pharmacology

P1476

Activated immune cells in Parkinson's disease.

@en

P2093

Jun-Jun Cao

http://www.w3.org/2001/XMLSchema#string

Kang-Sheng Li

http://www.w3.org/2001/XMLSchema#string

Yan-Qin Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Functional recovery in parkinsonian monkeys treated with GDNF

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo

Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure

Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications

Epidemiology of Parkinson's disease

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.

Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism.

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.

Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease.

P2888

s11481-011-9280-9

P304

323-329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11481-011-9280-9

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21553347

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease